Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 19 and up Women only

Acetaminophen alone versus acetaminophen plus ibuprofen for pain after cesarean delivery

Official title: Efficacy of Intravenous Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen (Maxigesic®IV) in Multimodal Analgesia After Cesarean Section: a Randomized Controlled Trial

Run by Seoul National University Hospital · NCT06479122 · Data updated 2026-11-12

This will see if adding intravenous ibuprofen to IV acetaminophen gives better pain relief than acetaminophen alone for people after an elective cesarean delivery.

More Cesarean Section trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages19 Years and up
SexWomen only
Enrollment84 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedOctober 9, 2024
Main results expectedJune 25, 2026
Study endsAugust 25, 2026
Registry record updatedJune 4, 2025
Trial IDNCT06479122 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people having an elective cesarean at term (≥37+0 weeks), meeting weight and organ-function criteria and without contraindications to acetaminophen or ibuprofen.

Probably not a fit

People with contraindications such as NSAID or acetaminophen allergy, liver or kidney disease, peptic ulcer/upper GI bleeding, asthma related to NSAIDs, multiple pregnancy, low body weight, or those undergoing emergency cesarean are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 4 interventional study compares IV acetaminophen alone to a combined IV acetaminophen/ibuprofen product (Maxigesic® IV) given as part of multimodal analgesia after elective cesarean section. Participants scheduled for term elective cesarean (≥37 weeks) will receive one of the two analgesic regimens and have postoperative pain scores and analgesic use recorded. The trial is conducted at a single center, Seoul National University Hospital, with standard perioperative care otherwise unchanged. Key exclusions include emergency cesarean, multiple pregnancy, significant liver or kidney disease, NSAID or acetaminophen hypersensitivity, and other contraindications listed in the protocol.

Why it matters

Potential benefit: If successful, the combination regimen could provide better postoperative pain control and reduce opioid requirements after cesarean delivery.

How similar studies have gone: Previous randomized trials have shown that combining acetaminophen (paracetamol) with ibuprofen improves postoperative pain control and reduces opioid use compared with acetaminophen alone, so this approach is supported by prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for elective cesarean section
* Gestational age \> 37+0 weeks

Exclusion Criteria:

* Emergency cesarean section
* Multiple pregnancy (e.g. twins, triplets)
* Body weight \< 50 kg
* Preeclampsia
* History of hypersensitivity to acetaminophen or ibuprofen
* History of upper gastrointestinal tract bleeding or gastric ulcer
* Underlying liver disease
* Underlying kidney disease or GFR \< 90 mL/min/1.73m2
* Heart failure or severe hypertension
* History of asthma
* Chronic use of barbital or tricyclic antidepressants

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.